Aimia Inc. announced leadership appointments aimed at fast-tracking the rollout of the Company's strategy recently endorsed by shareholders at its annual general meeting, naming James Scarlett as Chair of the newly-formed Strategic Review Committee. Aimia's strategy and near-term priorities are focused on unlocking value and returning capital to investors in a responsible and expeditious manner. The appointment is effective immediately.

James Scarlett, ICD.D., one of Canada's most respected senior legal advisors with more than 40 years of experience in complex merger and acquisition, capital markets, and other transactions and named to Aimia's Board in June 2024, has been appointed as Chair of Aimia's Strategic Review Committee. The newly-formed Board committee, which will include Aimia Directors Robert Feingold and Jordan Teramo, will work closely with management to drive Aimia's strategic review process and identify the best options for returning capital to shareholders. These options may include the potential sale of Aimia's core holdings, the potential spinoff of core holdings, the potential recapitalization of the Holdco or core holdings or the potential merger of core holdings with other entities to take advantage of the Company's cumulative tax losses.  Among its initial priorities, the Committee will work to identify the external advisors best qualified to assist Aimia in its strategic review process in the coming weeks.

Aimia expects the identification of best options for value creation to be completed in the third quarter of 2024.